Report Overview
Fibromyalgia syndrome (FS) is a non-articular rheumatic disorder characterized by pain and stiffness of the musculoskeletal system and tenderness in specific sites.Fibromyalgia syndrome can be secondary to trauma, a variety of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis and a variety of non-rheumatic diseases (such as hypothyroidism, malignant tumors).
This report provides a deep insight into the global Fibromyalgia Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Fibromyalgia Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Fibromyalgia Treatment market in any manner.
Global Fibromyalgia Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly and Company
Pfizer
Novartis AG
Allergan
Aptinyx
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma
Market Segmentation (by Type)
Antidepressants
Anticonvulsants
Muscle Relaxants
Narcotic Analgesics
Non-narcotic Analgesics
Market Segmentation (by Application)
Hospitals Pharmacies
Clinic Pharmacy
Retail Drug Stores
Online Pharmacies
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Fibromyalgia Treatment Market
? Overview of the regional outlook of the Fibromyalgia Treatment Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Fibromyalgia Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Fibromyalgia Treatment
1.2 Key Market Segments
1.2.1 Fibromyalgia Treatment Segment by Type
1.2.2 Fibromyalgia Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Fibromyalgia Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Fibromyalgia Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Fibromyalgia Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Fibromyalgia Treatment Market Competitive Landscape
3.1 Global Fibromyalgia Treatment Sales by Manufacturers (2019-2024)
3.2 Global Fibromyalgia Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Fibromyalgia Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Fibromyalgia Treatment Sales Sites, Area Served, Product Type
3.6 Fibromyalgia Treatment Market Competitive Situation and Trends
3.6.1 Fibromyalgia Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Fibromyalgia Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Fibromyalgia Treatment Industry Chain Analysis
4.1 Fibromyalgia Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Fibromyalgia Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Fibromyalgia Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Fibromyalgia Treatment Sales Market Share by Type (2019-2024)
6.3 Global Fibromyalgia Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Fibromyalgia Treatment Price by Type (2019-2024)
7 Fibromyalgia Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Fibromyalgia Treatment Market Sales by Application (2019-2024)
7.3 Global Fibromyalgia Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Fibromyalgia Treatment Sales Growth Rate by Application (2019-2024)
8 Fibromyalgia Treatment Market Segmentation by Region
8.1 Global Fibromyalgia Treatment Sales by Region
8.1.1 Global Fibromyalgia Treatment Sales by Region
8.1.2 Global Fibromyalgia Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Fibromyalgia Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Fibromyalgia Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Fibromyalgia Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Fibromyalgia Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Fibromyalgia Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Eli Lilly and Company
9.1.1 Eli Lilly and Company Fibromyalgia Treatment Basic Information
9.1.2 Eli Lilly and Company Fibromyalgia Treatment Product Overview
9.1.3 Eli Lilly and Company Fibromyalgia Treatment Product Market Performance
9.1.4 Eli Lilly and Company Business Overview
9.1.5 Eli Lilly and Company Fibromyalgia Treatment SWOT Analysis
9.1.6 Eli Lilly and Company Recent Developments
9.2 Pfizer
9.2.1 Pfizer Fibromyalgia Treatment Basic Information
9.2.2 Pfizer Fibromyalgia Treatment Product Overview
9.2.3 Pfizer Fibromyalgia Treatment Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Fibromyalgia Treatment SWOT Analysis
9.2.6 Pfizer Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Fibromyalgia Treatment Basic Information
9.3.2 Novartis AG Fibromyalgia Treatment Product Overview
9.3.3 Novartis AG Fibromyalgia Treatment Product Market Performance
9.3.4 Novartis AG Fibromyalgia Treatment SWOT Analysis
9.3.5 Novartis AG Business Overview
9.3.6 Novartis AG Recent Developments
9.4 Allergan
9.4.1 Allergan Fibromyalgia Treatment Basic Information
9.4.2 Allergan Fibromyalgia Treatment Product Overview
9.4.3 Allergan Fibromyalgia Treatment Product Market Performance
9.4.4 Allergan Business Overview
9.4.5 Allergan Recent Developments
9.5 Aptinyx
9.5.1 Aptinyx Fibromyalgia Treatment Basic Information
9.5.2 Aptinyx Fibromyalgia Treatment Product Overview
9.5.3 Aptinyx Fibromyalgia Treatment Product Market Performance
9.5.4 Aptinyx Business Overview
9.5.5 Aptinyx Recent Developments
9.6 Prismic Pharmaceuticals
9.6.1 Prismic Pharmaceuticals Fibromyalgia Treatment Basic Information
9.6.2 Prismic Pharmaceuticals Fibromyalgia Treatment Product Overview
9.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Product Market Performance
9.6.4 Prismic Pharmaceuticals Business Overview
9.6.5 Prismic Pharmaceuticals Recent Developments
9.7 Innovative Med Concepts
9.7.1 Innovative Med Concepts Fibromyalgia Treatment Basic Information
9.7.2 Innovative Med Concepts Fibromyalgia Treatment Product Overview
9.7.3 Innovative Med Concepts Fibromyalgia Treatment Product Market Performance
9.7.4 Innovative Med Concepts Business Overview
9.7.5 Innovative Med Concepts Recent Developments
9.8 Intec Pharma Ltd.
9.8.1 Intec Pharma Ltd. Fibromyalgia Treatment Basic Information
9.8.2 Intec Pharma Ltd. Fibromyalgia Treatment Product Overview
9.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Product Market Performance
9.8.4 Intec Pharma Ltd. Business Overview
9.8.5 Intec Pharma Ltd. Recent Developments
9.9 Astellas Pharma
9.9.1 Astellas Pharma Fibromyalgia Treatment Basic Information
9.9.2 Astellas Pharma Fibromyalgia Treatment Product Overview
9.9.3 Astellas Pharma Fibromyalgia Treatment Product Market Performance
9.9.4 Astellas Pharma Business Overview
9.9.5 Astellas Pharma Recent Developments
9.10 Savella
9.10.1 Savella Fibromyalgia Treatment Basic Information
9.10.2 Savella Fibromyalgia Treatment Product Overview
9.10.3 Savella Fibromyalgia Treatment Product Market Performance
9.10.4 Savella Business Overview
9.10.5 Savella Recent Developments
9.11 Sun Pharmaceutical Industries
9.11.1 Sun Pharmaceutical Industries Fibromyalgia Treatment Basic Information
9.11.2 Sun Pharmaceutical Industries Fibromyalgia Treatment Product Overview
9.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Product Market Performance
9.11.4 Sun Pharmaceutical Industries Business Overview
9.11.5 Sun Pharmaceutical Industries Recent Developments
9.12 Mylan NV
9.12.1 Mylan NV Fibromyalgia Treatment Basic Information
9.12.2 Mylan NV Fibromyalgia Treatment Product Overview
9.12.3 Mylan NV Fibromyalgia Treatment Product Market Performance
9.12.4 Mylan NV Business Overview
9.12.5 Mylan NV Recent Developments
9.13 Teva Pharmaceutical Industries
9.13.1 Teva Pharmaceutical Industries Fibromyalgia Treatment Basic Information
9.13.2 Teva Pharmaceutical Industries Fibromyalgia Treatment Product Overview
9.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Product Market Performance
9.13.4 Teva Pharmaceutical Industries Business Overview
9.13.5 Teva Pharmaceutical Industries Recent Developments
9.14 Daiichi Sankyo
9.14.1 Daiichi Sankyo Fibromyalgia Treatment Basic Information
9.14.2 Daiichi Sankyo Fibromyalgia Treatment Product Overview
9.14.3 Daiichi Sankyo Fibromyalgia Treatment Product Market Performance
9.14.4 Daiichi Sankyo Business Overview
9.14.5 Daiichi Sankyo Recent Developments
9.15 Forest Pharmaceuticals
9.15.1 Forest Pharmaceuticals Fibromyalgia Treatment Basic Information
9.15.2 Forest Pharmaceuticals Fibromyalgia Treatment Product Overview
9.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Product Market Performance
9.15.4 Forest Pharmaceuticals Business Overview
9.15.5 Forest Pharmaceuticals Recent Developments
9.16 Meiji Seika Pharma
9.16.1 Meiji Seika Pharma Fibromyalgia Treatment Basic Information
9.16.2 Meiji Seika Pharma Fibromyalgia Treatment Product Overview
9.16.3 Meiji Seika Pharma Fibromyalgia Treatment Product Market Performance
9.16.4 Meiji Seika Pharma Business Overview
9.16.5 Meiji Seika Pharma Recent Developments
9.17 Tonix Pharmaceuticals
9.17.1 Tonix Pharmaceuticals Fibromyalgia Treatment Basic Information
9.17.2 Tonix Pharmaceuticals Fibromyalgia Treatment Product Overview
9.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Product Market Performance
9.17.4 Tonix Pharmaceuticals Business Overview
9.17.5 Tonix Pharmaceuticals Recent Developments
9.18 Theravance Biopharma
9.18.1 Theravance Biopharma Fibromyalgia Treatment Basic Information
9.18.2 Theravance Biopharma Fibromyalgia Treatment Product Overview
9.18.3 Theravance Biopharma Fibromyalgia Treatment Product Market Performance
9.18.4 Theravance Biopharma Business Overview
9.18.5 Theravance Biopharma Recent Developments
10 Fibromyalgia Treatment Market Forecast by Region
10.1 Global Fibromyalgia Treatment Market Size Forecast
10.2 Global Fibromyalgia Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Fibromyalgia Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Fibromyalgia Treatment Market Size Forecast by Region
10.2.4 South America Fibromyalgia Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Fibromyalgia Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Fibromyalgia Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Fibromyalgia Treatment by Type (2025-2030)
11.1.2 Global Fibromyalgia Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Fibromyalgia Treatment by Type (2025-2030)
11.2 Global Fibromyalgia Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Fibromyalgia Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Fibromyalgia Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Fibromyalgia Treatment Market Size Comparison by Region (M USD)
Table 5. Global Fibromyalgia Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Fibromyalgia Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Fibromyalgia Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Fibromyalgia Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Treatment as of 2022)
Table 10. Global Market Fibromyalgia Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Fibromyalgia Treatment Sales Sites and Area Served
Table 12. Manufacturers Fibromyalgia Treatment Product Type
Table 13. Global Fibromyalgia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Fibromyalgia Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Fibromyalgia Treatment Market Challenges
Table 22. Global Fibromyalgia Treatment Sales by Type (Kilotons)
Table 23. Global Fibromyalgia Treatment Market Size by Type (M USD)
Table 24. Global Fibromyalgia Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Fibromyalgia Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Fibromyalgia Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Fibromyalgia Treatment Market Size Share by Type (2019-2024)
Table 28. Global Fibromyalgia Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Fibromyalgia Treatment Sales (Kilotons) by Application
Table 30. Global Fibromyalgia Treatment Market Size by Application
Table 31. Global Fibromyalgia Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Fibromyalgia Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Fibromyalgia Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Fibromyalgia Treatment Market Share by Application (2019-2024)
Table 35. Global Fibromyalgia Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Fibromyalgia Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Fibromyalgia Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Fibromyalgia Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Fibromyalgia Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Fibromyalgia Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Fibromyalgia Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Fibromyalgia Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. Eli Lilly and Company Fibromyalgia Treatment Basic Information
Table 44. Eli Lilly and Company Fibromyalgia Treatment Product Overview
Table 45. Eli Lilly and Company Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Eli Lilly and Company Business Overview
Table 47. Eli Lilly and Company Fibromyalgia Treatment SWOT Analysis
Table 48. Eli Lilly and Company Recent Developments
Table 49. Pfizer Fibromyalgia Treatment Basic Information
Table 50. Pfizer Fibromyalgia Treatment Product Overview
Table 51. Pfizer Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pfizer Business Overview
Table 53. Pfizer Fibromyalgia Treatment SWOT Analysis
Table 54. Pfizer Recent Developments
Table 55. Novartis AG Fibromyalgia Treatment Basic Information
Table 56. Novartis AG Fibromyalgia Treatment Product Overview
Table 57. Novartis AG Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis AG Fibromyalgia Treatment SWOT Analysis
Table 59. Novartis AG Business Overview
Table 60. Novartis AG Recent Developments
Table 61. Allergan Fibromyalgia Treatment Basic Information
Table 62. Allergan Fibromyalgia Treatment Product Overview
Table 63. Allergan Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Allergan Business Overview
Table 65. Allergan Recent Developments
Table 66. Aptinyx Fibromyalgia Treatment Basic Information
Table 67. Aptinyx Fibromyalgia Treatment Product Overview
Table 68. Aptinyx Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Aptinyx Business Overview
Table 70. Aptinyx Recent Developments
Table 71. Prismic Pharmaceuticals Fibromyalgia Treatment Basic Information
Table 72. Prismic Pharmaceuticals Fibromyalgia Treatment Product Overview
Table 73. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Prismic Pharmaceuticals Business Overview
Table 75. Prismic Pharmaceuticals Recent Developments
Table 76. Innovative Med Concepts Fibromyalgia Treatment Basic Information
Table 77. Innovative Med Concepts Fibromyalgia Treatment Product Overview
Table 78. Innovative Med Concepts Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Innovative Med Concepts Business Overview
Table 80. Innovative Med Concepts Recent Developments
Table 81. Intec Pharma Ltd. Fibromyalgia Treatment Basic Information
Table 82. Intec Pharma Ltd. Fibromyalgia Treatment Product Overview
Table 83. Intec Pharma Ltd. Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Intec Pharma Ltd. Business Overview
Table 85. Intec Pharma Ltd. Recent Developments
Table 86. Astellas Pharma Fibromyalgia Treatment Basic Information
Table 87. Astellas Pharma Fibromyalgia Treatment Product Overview
Table 88. Astellas Pharma Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Astellas Pharma Business Overview
Table 90. Astellas Pharma Recent Developments
Table 91. Savella Fibromyalgia Treatment Basic Information
Table 92. Savella Fibromyalgia Treatment Product Overview
Table 93. Savella Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Savella Business Overview
Table 95. Savella Recent Developments
Table 96. Sun Pharmaceutical Industries Fibromyalgia Treatment Basic Information
Table 97. Sun Pharmaceutical Industries Fibromyalgia Treatment Product Overview
Table 98. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sun Pharmaceutical Industries Business Overview
Table 100. Sun Pharmaceutical Industries Recent Developments
Table 101. Mylan NV Fibromyalgia Treatment Basic Information
Table 102. Mylan NV Fibromyalgia Treatment Product Overview
Table 103. Mylan NV Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Mylan NV Business Overview
Table 105. Mylan NV Recent Developments
Table 106. Teva Pharmaceutical Industries Fibromyalgia Treatment Basic Information
Table 107. Teva Pharmaceutical Industries Fibromyalgia Treatment Product Overview
Table 108. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Teva Pharmaceutical Industries Business Overview
Table 110. Teva Pharmaceutical Industries Recent Developments
Table 111. Daiichi Sankyo Fibromyalgia Treatment Basic Information
Table 112. Daiichi Sankyo Fibromyalgia Treatment Product Overview
Table 113. Daiichi Sankyo Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Daiichi Sankyo Business Overview
Table 115. Daiichi Sankyo Recent Developments
Table 116. Forest Pharmaceuticals Fibromyalgia Treatment Basic Information
Table 117. Forest Pharmaceuticals Fibromyalgia Treatment Product Overview
Table 118. Forest Pharmaceuticals Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Forest Pharmaceuticals Business Overview
Table 120. Forest Pharmaceuticals Recent Developments
Table 121. Meiji Seika Pharma Fibromyalgia Treatment Basic Information
Table 122. Meiji Seika Pharma Fibromyalgia Treatment Product Overview
Table 123. Meiji Seika Pharma Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Meiji Seika Pharma Business Overview
Table 125. Meiji Seika Pharma Recent Developments
Table 126. Tonix Pharmaceuticals Fibromyalgia Treatment Basic Information
Table 127. Tonix Pharmaceuticals Fibromyalgia Treatment Product Overview
Table 128. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Tonix Pharmaceuticals Business Overview
Table 130. Tonix Pharmaceuticals Recent Developments
Table 131. Theravance Biopharma Fibromyalgia Treatment Basic Information
Table 132. Theravance Biopharma Fibromyalgia Treatment Product Overview
Table 133. Theravance Biopharma Fibromyalgia Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Theravance Biopharma Business Overview
Table 135. Theravance Biopharma Recent Developments
Table 136. Global Fibromyalgia Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Fibromyalgia Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Fibromyalgia Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Fibromyalgia Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Fibromyalgia Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Fibromyalgia Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Fibromyalgia Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Fibromyalgia Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Fibromyalgia Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Fibromyalgia Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Fibromyalgia Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Fibromyalgia Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Fibromyalgia Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Fibromyalgia Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Fibromyalgia Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Fibromyalgia Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Fibromyalgia Treatment Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Fibromyalgia Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Fibromyalgia Treatment Market Size (M USD), 2019-2030
Figure 5. Global Fibromyalgia Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Fibromyalgia Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Fibromyalgia Treatment Market Size by Country (M USD)
Figure 11. Fibromyalgia Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Fibromyalgia Treatment Revenue Share by Manufacturers in 2023
Figure 13. Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Fibromyalgia Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Fibromyalgia Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Fibromyalgia Treatment Market Share by Type
Figure 18. Sales Market Share of Fibromyalgia Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Fibromyalgia Treatment by Type in 2023
Figure 20. Market Size Share of Fibromyalgia Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Fibromyalgia Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Fibromyalgia Treatment Market Share by Application
Figure 24. Global Fibromyalgia Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Fibromyalgia Treatment Sales Market Share by Application in 2023
Figure 26. Global Fibromyalgia Treatment Market Share by Application (2019-2024)
Figure 27. Global Fibromyalgia Treatment Market Share by Application in 2023
Figure 28. Global Fibromyalgia Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Fibromyalgia Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Fibromyalgia Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Fibromyalgia Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Fibromyalgia Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Fibromyalgia Treatment Sales Market Share by Country in 2023
Figure 37. Germany Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Fibromyalgia Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Fibromyalgia Treatment Sales Market Share by Region in 2023
Figure 44. China Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Fibromyalgia Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Fibromyalgia Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Fibromyalgia Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Fibromyalgia Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Fibromyalgia Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Fibromyalgia Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Fibromyalgia Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Fibromyalgia Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Fibromyalgia Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Fibromyalgia Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Fibromyalgia Treatment Market Share Forecast by Application (2025-2030)
